Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Health Information Cancer Screening Research

The Future of Ovarian Cancer Screening

At this time there’s no good test for early ovarian cancer. But physicians at RUSH University Medical Center are working to change that. Jacques Abramowicz, MD, section director for OB/GYN ultrasound at RUSH, and Jacob Rotmensch, MD, section director of gynecological oncology, are conducting research to develop a test to detect ovarian cancer at an earlier stage—when it is easier to treat—by using ultrasound contrast agents that would highlight any new blood vessels created by tumors.

The contrast agents help make visible even the smallest of blood vessels in ways that ultrasound alone can’t. If the research is successful, it could lead to the creation of a new early screening for ovarian cancer when used in conjunction with other screening approaches, such as a test for ovarian antibodies, developed by RUSH colleague Judith Luborsky, PhD.

Promotional Information

Discover Rush, 2005 - Spring
Past Issues
Cancer Screening Research

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois